Erectile dysfunction drug Viagra suddenly comes cheaper in Canada in a move by its maker, Pfizer, to compete with generic versions of the pill in the local market.
Pfizer's decision to drop its price came after the Canadian Supreme Court ruling invalidating the Viagra patent in Canada.
The giant pharmaceutical company obtained a patent in 1998 but was challenged by generic drug maker, Teva Canada Ltd., in the Federal Court of Appeals in 2007. Pfizer later prevailed in Federal Court ruling.
But in the November 8 ruling, the Supreme Court "sided with Teva Canada's challenge of the legitimacy of the patent, paving the way for generic versions." canadianbusiness.com reports.
"The ruling wiped out Pfizer's market dominance with Viagra. Its patent had been scheduled to expire in 2014," the report said.
Scott Wilks of Pfizer Canada says the decision to lower the cost reflects the company’s commitment to ensuring patients have access to the original Viagra at a competitive price, the financialpost.com writes.
"We are lowering original Viagra’s price to be in line with generic versions because we are committed to ensuring that Viagra patients continue to have access to the original — made by Pfizer, and at a competitive price,” Wilks added.
The Supreme Court ruling which takes effect immediately, will result in a drastic downward cut in the price of the blue pill.
Julie-Catherine Racine, spokesperson of Pfizer said the price of Viagra pack containing four 100 ml. pills has been cut from $49 to $37.00. The price is now in full effect, she added.
Sildenafil citrate, sold in the market as "Viagra" is a drug used to treat erectile dysfunction and pulmonary arterial hypertension (PAH).
According to Wikipedia, "the dose of sildenafil for erectile dysfunction is 25 mg to 100 mg taken not more than once per day between 30 minutes and 4 hours prior to sexual intercourse."
Viagra is a prescription drug and users are advised to seek doctors prescription before taking the drug.